Chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) are two important causes of mortality and morbidity in our country and are among top 10 causes of death.[1] The interrelationship between TB and COPD is very complex. A substantial number of TB patients develop posttubercular airway disease or TB-associated COPD.[2,3,4,5] This is the most commonly reported relationship. However, many different associations have also been published.
COPD patients are also at high risk of developing pulmonary TB[6]
COPD is a common comorbidity in patients with TB, second only to diabetes[7,8,9,10]
History of TB negatively impacts the long-term course of COPD with early mortality and increased frequency of exacerbations[11]
COPD also alters the clinical presentation of TB and is a risk factor for increased morbidity and mortality from TB.[12,13]
In the article by Agarwal et al. published in this issue of Lung India, 32.4% of COPD patients had a history of TB.[14] In the PLATINO study which compared COPD patients with and without TB history, it was found that airway obstruction was observed in 30.7% of patients with a positive history of TB, while the incidence for the same was only 13%–9% in those without a prior history.[15] In our study on gender differences in COPD, history of TB was present in 28.4% of males and 29.7% of females.[3]
Even a study from Columbia has reported that the association between TB and airway obstruction was stronger than that observed between smoking and airway obstruction.[16] Yakar et al. evaluated the effect of TB history on natural course of COPD' according to them, patient with history of TB was diagnosed with COPD 5 years earlier, hospitalized more often due to COPD exacerbations, and had a life expectancy 5 years shorter[11] Further, these patients with COPD secondary to TB have been shown to have significantly low forced expiratory volume in 1 s, higher airway resistance, and poor positive bronchodilator response (27% vs. 82%) than only COPD patients.[17] The abnormalities in lung functions were significantly associated with extent of lung involvement with TB, duration of disease, episodes of TB and age over 40 years.[10,18,19]
Tobacco smoking is a major factor in the development of COPD. The association between cigarette smoking, accelerated loss of lung functions, and COPD is well established.[20,21]
Cigarette smoking also increases the risk of developing TB by 3–5 folds.[22,23] TB in smokers takes a more severe disseminated course, more extensive lung involvement, and less cavity closure.[12]
In a recent study from Taiwan on a large sample of 5567 TB patients, it was observed that smoking tobacco doubles the risk of recurrent TB.[24]
Smoking, TB, and COPD all damages the lungs. Smoking suppresses the innate and adaptive immune response with decreased levels of pro-inflammatory cytokines and circulating immunoglobulins and reduces the activity of alveolar macrophages, dendritic cells, and natural killer cells.[25,26]
Antigenic wall component of Mycobacterium tuberculosis lioparabinomannan stimulates the release of matrix metalloproteinases (MMPs).[27,28] The increased expression of MMPs, CD8 lymphocytes, neutrophils, interleukin 8 and vascular endothelial growth pathway results in structural changes seen in COPD. This complex interrelationship of smoking, COPD, and TB with increased expression of proteolytic enzymes, cytokines, and interleukins results in the structural damage seen in both COPD and TB.[29,30]
Smoking, however, is not the sole factor in the pathogenesis of COPD and TB and the structural lung damage seen as all the smokers do not develop COPD and COPD is known to occur in nonsmokers.[31] In a study of COPD in never smokers, only 5.3% of COPD patients had a history of TB.[32] It appears that susceptibility of an individual to develop active TB and COPD involves a complex interaction between genetic and environment, and the result depends on the net result of protease, anti-protease imbalance, and the extent of oxidative stress.[30,33,34,35]
The study by Agarwal et al. shows only one side of this association, there is strong need of further research on this complex interaction to determine the exact clinical presentation, further course of TB in COPD and COPD in TB how adversely affects the disease progression, morbidity, and mortality.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- 1.India/Institute for Health Metrics and Evaluation. [Last seen on 2017 Jun 21]. Available from: http://www.Health.Org>India .
- 2.Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis. 1971;103:625–40. doi: 10.1164/arrd.1971.103.5.625. [DOI] [PubMed] [Google Scholar]
- 3.Jain NK, Thakkar MS, Jain N, Rohan KA, Sharma M. Chronic obstructive pulmonary disease: Does gender really matter? Lung India. 2011;28:258–62. doi: 10.4103/0970-2113.85686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Verma SK, Kumar S, Narayan K, Sodhi R. Post tubercular obstructive airway impairment. Indian J Allergy Asthma Immunol. 2009;23:95–9. [Google Scholar]
- 5.Zakaria M, Moussa H. Chronic obstructive pulmonary disease in treated pulmonary tuberculosis patients. Egypt J Bronchol. 2015;9:10–3. [Google Scholar]
- 6.Lee CH, Lee MC, Star CC, Lim CS, Wang JY, Lee LN, et al. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: A nationwide cohort study. BMC Infect Dis. 2013;13:194–6. doi: 10.1186/1471-2334-13-194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Aktogu S, Yorgancioglu A, Cirak K, Köse T, Dereli SM. Clinical spectrum of pulmonary and pleural tuberculosis: A report of 5,480 cases. Eur Respir J. 1996;9:2031–5. doi: 10.1183/09031936.96.09102031. [DOI] [PubMed] [Google Scholar]
- 8.Didilescu C, Ibraim E, Plopeanu D. A study of the risk factors for relapse in pulmonary tuberculosis patients and the results of the re-treatment. Pneumologia. 2000;49:247–52. [PubMed] [Google Scholar]
- 9.Wang JY, Lee LN, Hsueh PR. Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2005;9:777–83. [PubMed] [Google Scholar]
- 10.Rizvi N, Shah RH, Inayat N, Hussain N. Differences in clinical presentation of pulmonary tuberculosis in association with age. J Pak Med Assoc. 2003;53:321–4. [PubMed] [Google Scholar]
- 11.Yakar HI, Gunen H, Pehlivan E, Aydogan S. The role of tuberculosis in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:323–9. doi: 10.2147/COPD.S116086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Shprykov AS, Zhadnov VZ. Effects of tobacco smoking on the course of infiltrative pulmonary tuberculosis and effectiveness of its treatment. Probl Tuberk. 1994;5:26–7. [PubMed] [Google Scholar]
- 13.Leung CC, Yew WW, Chan CK, Tam CM, Lam CW, Chang KC, et al. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2003;7:980–6. [PubMed] [Google Scholar]
- 14.Agarwal D, Gupta A, Janmeja AK, Bhardwaj M. Evaluation of tuberculosis associated chronic obstructive pulmonary disease at a tertiary care hospital: A case control study. Lung India. 2017;34:415–9. doi: 10.4103/lungindia.lungindia_522_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Menezes AM, Hallal PC, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, et al. Tuberculosis and airflow obstruction: Evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30:1180–5. doi: 10.1183/09031936.00083507. [DOI] [PubMed] [Google Scholar]
- 16.Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study) Chest. 2008;133:343–9. doi: 10.1378/chest.07-1361. [DOI] [PubMed] [Google Scholar]
- 17.Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med. 2003;97:1237–42. doi: 10.1016/s0954-6111(03)00255-5. [DOI] [PubMed] [Google Scholar]
- 18.Birath G, Caro J, Malmberg R, Simonsson BG. Airways obstruction in pulmonary tuberculosis. Scand J Respir Dis. 1966;47:27–36. [PubMed] [Google Scholar]
- 19.Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55:32–8. doi: 10.1136/thorax.55.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645–8. doi: 10.1136/bmj.1.6077.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Maurya V, Vijayan VK, Shah A. Smoking and tuberculosis: An association overlooked. Int J Tuberc Lung Dis. 2002;6:942–51. [PubMed] [Google Scholar]
- 22.Davies PD, Yew WW, Ganguly D, Davidow AL, Reichman LB, Dheda K, et al. Smoking and tuberculosis: The epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg. 2006;100:291–8. doi: 10.1016/j.trstmh.2005.06.034. [DOI] [PubMed] [Google Scholar]
- 23.Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: A systematic review and meta-analysis. Arch Intern Med. 2007;167:335–42. doi: 10.1001/archinte.167.4.335. [DOI] [PubMed] [Google Scholar]
- 24.Yen YF, Yen MY, Lin YS, Lin YP, Shih HC, Li LH, et al. Smoking increases risk of recurrence after successful anti-tuberculosis treatment: A population-based study. Int J Tuberc Lung Dis. 2014;18:492–8. doi: 10.5588/ijtld.13.0694. [DOI] [PubMed] [Google Scholar]
- 25.Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206–16. doi: 10.1001/archinte.164.20.2206. [DOI] [PubMed] [Google Scholar]
- 26.Pai M, Mohan A, Dheda K, Leung CC, Yew WW, Christopher DJ, et al. Lethal interaction: The colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther. 2007;5:385–91. doi: 10.1586/14787210.5.3.385. [DOI] [PubMed] [Google Scholar]
- 27.Hrabec E, Strek M, Zieba M, Kwiatkowska S, Hrabec Z. Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis. 2002;6:713–9. [PubMed] [Google Scholar]
- 28.Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 2006;61:259–66. doi: 10.1136/thx.2005.051979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sundarajan S, Babu S, Das SD. Comparison of localised versus systemic levels of matrix metalloproteinases (MMPs) in tissue inhibitors and cytokines in tuberculosis and non-tubercular pleurosis. Hum Immunol. 2012;73:985–91. doi: 10.1016/j.humimm.2012.07.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol. 2001;429:195–207. doi: 10.1016/s0014-2999(01)01320-6. [DOI] [PubMed] [Google Scholar]
- 31.Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–43. doi: 10.1016/S0140-6736(09)61303-9. [DOI] [PubMed] [Google Scholar]
- 32.Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, et al. COPD in never smokers: Results from the population-based burden of obstructive lung disease study. Chest. 2011;139:752–63. doi: 10.1378/chest.10-1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, et al. Not 15 but 50% of smokers develop COPD.Report from the Obstructive Lung Disease in Northern Sweden Studies? Respir Med. 2003;97:115–22. doi: 10.1053/rmed.2003.1446. [DOI] [PubMed] [Google Scholar]
- 34.Chakrabarti B, Calverley PM, Davies PD. Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007;2:263–72. [PMC free article] [PubMed] [Google Scholar]
- 35.Alcaïs A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: Two distinct genetic diseases. J Exp Med. 2005;202:1617–21. doi: 10.1084/jem.20052302. [DOI] [PMC free article] [PubMed] [Google Scholar]